GoodRx Slips on Surprise Loss After IPO Costs

This post was originally published on this site
© Reuters. © Reuters.

By Christiana Sciaudone — Goodrx Holdings Inc (NASDAQ:) fell 6.6% on Thursday after reporting a surprise loss for the quarter in its first earnings release as a public company.

The tele-medicine and digital prescription platform, which went public in September, posted an adjusted loss per share of 21 cents on $140.5 million in revenue. Analysts were calling for earnings of 9 cents a share.

GoodRx cited an increase in stock-based compensation related to the company’s IPO for the loss.

The fourth quarter and full-year forecasts were better. The company said it expects about $148 million in the current period and about $545 million for the year, both of which topped consensus.

GoodRx also said its monthly active users rebounded after dipping in the previous quarter. The company had 4.9 million MAUs, topping both the second quarter’s 4.4 million and the 3.8 million from a year earlier.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.